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OBJECTIVES: To determine the awakening arterial blood concentration of desflurane and its relationship with
the end-tidal concentration during emergence from various durations of general anesthesia.
METHOD: In total, 42 American Society of Anesthesiologists physical status class I-II female patients undergoing
elective gynecologic surgery were enrolled. General anesthesia was maintained with fixed 6% inspiratory
desflurane in 6 l min-1 oxygen until shutoff of the vaporizer at the end of surgery. One milliliter of arterial
blood was obtained for desflurane concentration determination by gas chromatography at 20 and 10 minutes
before and 0, 5, 10, 15, and 20 minutes after the discontinuation of desflurane and at the time of eye opening
upon verbal command, defined as awakening. Concentrations of inspiratory and end-tidal desflurane were
simultaneously detected by an infrared analyzer.
RESULTS: The mean arterial blood concentration of desflurane was 1.20% at awakening, which correlated with
the awakening end-tidal concentration of 0.96%. The mean time from the discontinuation of desflurane to eye
opening was 5.2 minutes (SD=1.6, range 3-10), which was not associated with the duration of anesthesia (60-
256 minutes), total fentanyl dose, or body mass index (BMI).
CONCLUSIONS: The mean awakening arterial blood concentration of desflurane was 1.20%. The time to
awakening was independent of anesthetic duration within four hours. Using well-assisted ventilation, the end-
tidal concentration of desflurane was proven to represent the arterial blood concentration during elimination
and could be a clinically feasible predictor of emergence from general anesthesia.
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& INTRODUCTION
Desflurane has been clinically used in anesthesia for two
decades (1). The major advantages include rapid induction
and recovery (2,3), lower cost (4), and myocardial protection
during cardiac surgery (5). Due to its lower blood-gas partition
coefficient (0.42), the ratio of the dissolved amount in the blood
to the amount in the alveolar gas in contact with the blood,
desflurane has been clearly proven to provide a shorter time to
extubation compared with sevoflurane (20% reduction) (2)
and isoflurane (34% reduction) (3), especially in those
individuals undergoing prolonged surgical procedures (4,6).
Growing evidence (7-12) indicates that a certain time period
is needed for inhaled anesthetics to cross the alveolar
membrane and enter the body and brain in the beginning of
general anesthesia in order to achieve the minimal alveolar
concentration (MAC), the point at which no movement is
observed in 50% of patients in response to a surgical stimulus.
Similarly, elimination of the inhaled anesthetics from the
blood to the lungs during emergence is time-dependent (13).
Clinically, the end-tidal concentration has been a feasible
predictor of awakening from general anesthesia (14).
However, irregular respiration during emergence usually
results in the fluctuation of end-tidal concentrations of inhaled
anesthetics (15). The arterial blood concentration provides a
steadier, more reliable representation of the anesthetic
concentration in the brain. Thus, we hypothesized that
desflurane, with its low coefficient, would not accumulate in
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the blood and delay emergence after a prolonged duration of
general anesthesia. In addition, due to the rapid elimination of
desflurane, the end-tidal concentration could reflect the
arterial blood concentration during well-assisted ventilation
and be used to predict awakening during emergence.
The primary aim of this study was to examine the arterial
blood concentration of desflurane during emergence and the
time to awakening after various durations of general anesthe-
sia. The secondary aim was to examine the validity of the
noninvasively determined end-tidal concentration of desflur-
ane as a reliable indicator of the arterial blood concentration.
& MATERIALS AND METHODS
Patients
After obtaining approval of Institutional Review Board
(TSGHIRB-097-05-189) and written informed consent, 42
ASA I or II 20- to 60-year-old gynecologic patients scheduled
for elective surgery under general anesthesia were included.
Patients with severe cardiopulmonary diseases, irritable
airways, such as ongoing asthma or acute upper respiratory
infection, hepatic diseases (16), neuropapthy, or regular
hypnotic or sedative use were excluded.
Anesthetic management and gas monitoring
In the operating room, after premedication with 100 mcg
intravenous fentanyl and 0.5 ml subcutaneous 2% lidocaine,
a 20-gauge catheter was placed into the left radial artery for
blood sampling. General anesthesia was induced with 1.5 mg
kg-1 propofol, and 1.5 mg kg-1 succinylcholine was adminis-
tered for endotracheal intubation. We maintained anesthesia
with 0.1 mg kg-1 cis-atracurium and 6% fixed inspiratory
desflurane in 6 l min-1 oxygen during the entire procedure.
Nitrous oxide was not used. Fentanyl, 25 or 50 mcg, was
titrated to meet the patients’ pain responses beyond
desflurane administration. A Datex-Ohmeda Aestiva/5
anesthetic machine (Datex-Ohmeda, Madison, WI) was used
with soda lime (CO2 absorbent), and the minute ventilation
was adjusted to keep the end-tidal CO2 between 38 and
42 mmHg. The leakage of each system was determined using
constant-pressure ventilation with a test lung. The sampled
gases (approximately 210 ml min-1) were redirected into the
circuit. Both the inspiratory and the end-tidal concentrations
of desflurane were detected by an infrared multi-gas analyzer
(Datex-Ohmeda S/5 Anesthesia System; Datex-Ohmeda,
Helsinki, Finland) that was calibrated according to the
manufacturer’s recommendations. A Finometer (FMS, Finapres
Measurement Systems, Arnhem, Netherlands) was used to
determine cardiac output. Hypotension, defined as a 25%
decrease in blood pressure from baseline, was treated with
intravenous fluid and ephedrine (5 mg bolus). A nasophar-
yngeal thermometer was used to measure and maintain the
body temperature in the range of 36.5-37.5 C˚. After the
operation was completely finished, the vaporizer was
turned off, with 6 l min-1 oxygen for fresh gas flow. Next,
2 mg Neostigmine and 0.4 mg glycopyrrolate were admi-
nistered intravenously to reverse the neuromuscular
blockade. The end-tidal CO2 was maintained between 38
and 42 mmHg with manually assisted ventilation under
quiet circumstances, without additional stimulation.
Awakening was defined as eye opening upon verbal
command and was tested every 30 seconds after the
discontinuation of desflurane until the appropriate
response. Extubation was accomplished after brief endo-
tracheal suction. The time from the discontinuation of
desflurane to awakening and the duration of surgery and
Table 1 - Characteristics of patients (N=42).
Characteristics Mean (SD) Range Median
Age, years 40.8 (9.7) 24-57 41.0
Weight, kg 61.0 (10.1) 45-85 59.5
Height, cm 161.0 (6.0) 148-174 161.0
Body mass index, kg m-2 23.5 (3.6) 17.6-32.0 23.0
Fentanyl, mcg kg-1 2.5 (0.8) 1.4-4.6 2.4
Duration of anesthesia,
min
127.9 (44.0) 60-256 122
Time to eye opening, min 5.2 (1.6) 3-10 5
Table 2 - The arterial blood, inspiratory, and end-tidal concentrations of desflurane during emergence from general
anesthesia in gynecologic patients (N=42).
Time (min) -20 -10 0 5 Eye Opening 10 15 20
Arterial concentration 3.91 (0.37) 3.87 (0.35) 3.82 (0.45) 1.17 (0.29) 1.20 (0.30) 0.73 (0.16) 0.57 (0.18) 0.48 (0.17)
Inspiratory
concentration
6.01 (0.14) 6.01 (0.12) 5.99 (0.11) 0.01 (0.04) 0.08 (0.13)
End-tidal concentration 5.62 (0.19) 5.61 (0.18) 5.62 (0.15) 1.02 (0.31) 0.96 (0.32) 0.54 (0.17) 0.43 (0.14) 0.33 (0.15)
The values are presented as means (SD). The mean time to eye opening was 5.2 (1.6) minutes.
0 min: Immediately prior to the discontinuation of 6% desflurane.
Table 3 - Hemodynamic and ventilatory variables during emergence (N=42).
Time -20 -10 0 5 Eye Opening 10 15 20
HR 71 (14.8) 74 (19.9) 75 (15.5) 110 (21.2) 114 (17.7) 91 (15.0) 82 (14.5) 78 (13.5)
MAP 94.8 (17.1) 97.1 (15.5) 95.5 (16.1) 117.4 (16.2) 119.8 (21.7) 104.2 (16.5) 98.3 (16.3) 102.2 (14.6)
CO 5.4 (1.7) 5.9 (1.6) 5.3 (1.3) 6.0 (1.8) 5.8 (1.9) 5.9 (1.5) 5.6 (1.7) 5.4 (1.6)
CI 2.7 (1.0) 3.1 (0.9) 2.8 (0.7) 3.1 (1.0) 3.1 (1.1) 3.1 (1.0) 3.0 (0.8) 2.7 (0.8)
TPR 1576 (446) 1483 (456) 1518 (448) 1803 (633) 1795 (616) 1619 (546) 1668 (547) 1738 (761)
ETCO2 39.1 (3.8) 39.8 (2.7) 39.8 (1.8) 41.2 (6.2) 41.3 (6.7) 40.4 (5.7) 40.1 (6.5) 39.9 (6.9)
The values are presented as means (SD). The mean time to eye opening was 5.2 (1.6) minutes.
HR, heart rate; MAP, mean arterial blood pressure; CO, cardiac output; CI, cardiac index; TPR, total physical response; ETCO2, end-tidal CO2.
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anesthesia were recorded. Inspiratory concentration,
expired concentration, end-tidal CO2, blood pressure, heart
rate, and body temperature data were recorded every 30
seconds by commercial software (Datex-Ohmeda S/5
Collect; Datex-Ohmeda, Madison, WI) until 20 minutes
after the discontinuation of desflurane.
Figure 1 - The correlation between the duration of anesthesia and the arterial concentration of desflurane before discontinuation and
at awakening. The arterial concentrations immediately prior to discontinuing 6% desflurane (upper) and at awakening (middle) and
the awakening end-tidal concentration (lower) were not correlated with the duration of general anesthesia (60-256 minutes).
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Determination of the arterial blood concentration
of desflurane during elimination
Prior to induction, 10 ml of blood was collected from each
patient to determine the blood-gas partition coefficient (l)
of desflurane (8). In each blood sample, Desflurane was
converted to the corresponding concentration, based on gas
chromatographic measurements, and the blood-gas parti-
tion coefficient of desflurane (l) was measured.
Gas chromatography conditions
The HP 6890 series GC system (Hewlett-Packard,
Wilmington, DE) consists of a headspace sampler (Agilent
G1888), an oven, a flame ionization detector, and an
integrator. The carrier gas (helium) flow was 25.0 ml
min-1. Separation was achieved with a capillary column
(HP-5; 30.0 m?0.32 mm ID, 0.25 mm film thickness) (Restek,
Bellefonte, PA). An integrator and a data acquisition system
were provided by HP CHEMOSTATION software. The
method used to create a calibration curve for measuring the
blood desflurane concentration was modified according to a
previous publication (8).
Statistical analysis
Means (SD), ranges, and medians (for the time to eye
opening) were used to describe the patients’ characteristics.
Clinical parameters were presented as mean (SD) over time.
Bivariate relationships between variables were analyzed
by simple linear regressions and Pearson correlations.
Moreover, a Bland-Altman agreement analysis was used
to determine the degree of agreement between the awaken-
ing arterial blood and end-tidal desflurane concentrations
at three times to awakening with the aid of MedCalc version
12.2.1.0 (MedCalc Software, Marikerke, Belgium). A p-
value,0.05 was considered statistically significant.
& RESULTS
Demographic data and anesthetics are summarized in
Table 1. The mean time from the discontinuation of
desflurane to eye opening upon verbal command was 5.2
(1.6) minutes (range 3-10, median 5 minutes). In total, 10 mg
Ephedrine was administered to each of four patients to
lower blood pressure after induction and before surgical
incision.
Table 2 lists the arterial blood, inspiratory, and end-tidal
concentrations of desflurane before and during emergence.
Before the discontinuation of desflurane, the arterial con-
centration was 3.82 (0.45) %, and the end-tidal concentration
was 5.62 (0.15) %. These values decreased to 1.20 (0.30) % and
0.96 (0.32) %, respectively, at awakening. The decrease in the
end-tidal concentration was more prominent than the
decrease in the arterial concentration in the initial five
minutes after discontinuation. The hemodynamic and venti-
latory variables during emergence were within 20% of the
preoperative baseline, without apparent differences (Table 3).
As shown in Figure 1, the arterial concentrations before
discontinuing desflurane and at awakening and the awa-
kening end-tidal concentration were not significantly
correlated with the duration of general anesthesia, with
p= 0.056, 0.197, and 0.177, respectively. Despite a larger
scale of variation, the awakening end-tidal concentration
(range 0.19-1.99%, with a 95% confidence interval of 0.33-
1.59%) significantly represented the arterial concentration at
awakening (range 0.63-1.85%, with a 95% confidence
interval of 0.58-1.74%) (p= 0.001).
The Bland-Altman plot (Figure 2) displays the difference
between the arterial and the end-tidal concentrations at
awakening plotted against the average of the two concen-
trations. The difference ranged from -0.51 to 1.19% and fell
into an acceptable range (¡1.96 SD), regardless of the length
Figure 2 - Bland-Altman plot displaying the difference between the awakening arterial blood and end-tidal concentrations plotted
against the average of the two concentrations. The differences were mostly within the ¡1.96 SD range.
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of awakening time. The arterial concentration at awakening
was systematically higher than the end-tidal concentration,
with a median of 0.2%.
The possible contributing factors upon awakening are also
analyzed in Figure 3. The time to awakening was within 3-10
minutes, with a 95% confidence interval of 2.2-8.3 minutes. In
total, 50% of awakening occurred within five minutes, and
90% occurred within seven minutes, which was not
prolonged by the duration of anesthesia, ranging from 60-
256 minutes, and was not correlated with the total fentanyl
dose (p= 0.232) or body mass index (BMI) (p= 0.356).
& DISCUSSION
This is the first study to quantitatively demonstrate an
awakening arterial blood concentration of desflurane of 1.20
(0.30) % in gynecologic surgery patients. Increasing the
duration of desflurane anesthesia to a maximum of four hours
did not elevate the arterial concentration before the disconti-
nuation of desflurane and did not prolong the awakening time.
During well-assisted ventilation, the end-tidal concentration of
desflurane represents the higher arterial concentration at
awakening and provides a feasible predictor of eye opening
after a surgical procedure completed within 60-256 minutes.
The total body uptake and elimination of inhaled anes-
thetics are supposed to be proportional to the duration of
general anesthesia (17,18). However, the lower blood-gas and
blood-tissue partition coefficients of desflurane theoretically
limit total body uptake, facilitating elimination in patients
with longer-duration anesthetics and a higher BMI (19,20).
Rohm et al. (4) demonstrated that patients undergoing
prolonged surgical procedures (.150 min) showed faster
recovery and required lower expenditure after a desflurane/
fentanyl regimen than a propofol/remifentanil regimen.
Faster recovery following desflurane, compared with iso-
flurane, may be desirable after long surgical procedures (.5
hours) (6), enabling the patient’s full cooperation and
facilitating the early diagnosis of any potential neurological
deficit. Nordmann et al. (21) also demonstrated that increas-
ing the duration of inhalation anesthesia is associated with
slower emergence and recovery in children, but this effect
was less evident with desflurane compared with isoflurane.
In this study, the arterial blood concentration of desflurane
provided convincing evidence for the above findings. The
arterial concentration before the discontinuation of desflur-
ane was not correlated with the duration of anesthesia (60-
256 min). In addition, the time to awakening mostly ranged
between three and seven minutes in 39 of 42 patients and was
not proportionally prolonged by the duration of anesthesia,
further indicating limited total uptake and rapid alveolar
washout during elimination.
The rate of uptake of inhaled anesthetics is dependent on
the alveolar concentration and ventilation, blood solubility,
and cardiac output (22). During the elimination phase,
desflurane washout progresses from the brain and body to
the alveolar space via the circulating blood, allowing the
lungs to ventilate the anesthetic into the air. The end-tidal
CO2 may depict the status of the minute ventilation and
cardiac output. Hypoventilation delays the alveolar washout
of inhaled anesthetics. However, higher blood CO2 levels
elevate cardiac output and cerebral blood flow, which
reversely accelerate the elimination of desflurane from the
brain. Currently, no direct markers are available to adjust the
above impact of alveolar washout and cerebral blood flow in
clinical practice. Eventually, when the brain or arterial
concentration decreases to a certain level, the patient awakens
enough to respond to the verbal command for eye opening. By
determining arterial blood concentrations, the clinical influ-
ence of the minute ventilation and cardiac output on the
elimination of inhaled anesthetics can be clarified. In this
Figure 3 - The time to awakening after discontinuation of 6%
desflurane was not prolonged by the duration of anesthesia and
was not correlated with the total fentanyl dose or body mass
index.
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study, the minute ventilation and cardiac index of all patients
were kept steady before extubation, which revealed a
correlation between the awakening arterial blood and end-
tidal desflurane concentrations. The end-tidal concentration
of desflurane decreased more prominently during the initial
five minutes after discontinuation and became persistently
lower than the arterial concentration, indicating rapid alveolar
washout. Compared with the simultaneous arterial blood
level, the end-tidal concentration of desflurane was identified
as a feasible predictor of emergence from general anesthesia.
There are certain limitations of the current study. First, the
minute ventilation could hardly be controlled by a ventilator
after the reversal of spontaneous breathing during emergence.
We, therefore, manually assisted the ventilation to maintain
the end-tidal CO2 level between 38 and 42 mmHg before
extubation. Despite greater fluctuation, the awakening end-
tidal concentration represented the actual arterial concentra-
tion in this study. Second, all of our patients were female.
Women are generally reported to have greater sensitivity to
pain than men, and healthy young women require 20% more
anesthetics than do healthy age-matched men to prevent
movement in response to noxious electrical stimulation (23).
A higher MAC has been reported for desflurane-6.2% for
women compared to 6.0% for men-although the difference is
insignificant (24). Additionally, a longer eye-opening time
after general anesthesia with desflurane has been reported-6.0
(1.3) minutes in female patients and 4.9 (0.9) minutes in male
patients (p,0.001) (25). Further investigation is needed to
verify the gender effect on the awakening arterial blood
concentration. Third, the patients received up to four hours of
anesthesia, and the maximal BMI was close to 32 kg m22. The
clinical inferences should be adjusted based on a patient’s
outlying factors, such as morbid obesity and a more
prolonged duration of anesthesia.
In conclusion, we are the first to demonstrate the
awakening arterial concentration of desflurane in gyneco-
logic patients. The arterial concentrations before disconti-
nuation and at awakening were not significantly elevated by
the increasing duration of desflurane anesthesia (1-4 hours),
which was consistent with the rapid awakening time,
indicating suitability for a prolonged duration of anesthesia.
Using well-assisted ventilation during emergence, the end-
tidal concentration of desflurane can be a feasible predictor
of awakening from general anesthesia.
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